Why the study?
Larger studies and synthesized evidence are needed to determine whether myocardial work can be widely implemented into clinical practice for assessing left ventricular dysfunction caused by myocardial ischemia and hyperglycemia.
Does echocardiographic myocardial work improve the assessment of left ventricular function compared to conventional parameters in patients with coronary artery disease and diabetes mellitus?
Does echocardiographic myocardial work improve the assessment of left ventricular function compared to conventional parameters in patients with coronary artery disease and diabetes mellitus?
Echocardiographic myocardial work is a promising novel tool that incorporates deformation and load to assess LV systolic function in patients with CAD and diabetes, potentially offering advantages over LVEF and GLS.
Myocardial work may refine LV assessment in DM with CAD; leaves open prospective outcome validation before practice change.
Myocardial ischemia caused by coronary artery disease (CAD) and the presence of metabolic abnormalities and microvascular impairments detected in patients with diabetes mellitus (DM) are a common cause of left ventricular (LV) dysfunction. Transthoracic echocardiography is the most-used, non-invasive imaging method for the assessment of myocardial contractility. The accurate evaluation of LV function is crucial for identifying patients who are at high risk or may have worse outcomes. Myocardial work (MW) is emerging as an alternative tool for the evaluation of LV systolic function, providing additional information on cardiac performance when compared to conventional parameters such as left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) because it incorporates deformation and load into its analysis. The potential of MW in various conditions is promising and it has gained increased attention. However, larger studies are necessary to further investigate its role and application before giving an answer to the question of whether it can have widespread implementation into clinical practice. The aim of this review is to summarize the actual knowledge of MW for the analysis of LV dysfunction caused by myocardial ischemia and hyperglycemia.
No takes yet. Share an insight, caveat, or question.
Frișan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: